Login / Signup

Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase.

Khac Cuong BuiThi Mai Ly NguyenSamarpita BaratTim ScholtaJun XingVikas BhuriaBence SiposLudwig WilkensLinh Toan NguyenHuu Song LeThirumalaisamy P VelavanPrzemyslaw BozkoRuben R Plentz
Published in: Current medicinal chemistry (2024)
AdipoR1 and p-AMPKα are impaired in CCA tissues, and AdipoRon effectively inhibits CCA in vitro and in vivo. Thus, AdipoRon may be considered as a potential anti-tumor therapy in CCA.
Keyphrases
  • protein kinase
  • metabolic syndrome
  • gene expression
  • skeletal muscle
  • insulin resistance
  • stem cells
  • type diabetes
  • adipose tissue
  • mesenchymal stem cells
  • replacement therapy
  • smoking cessation